Search Browse Earnings

Landos Biopharma, Inc.

Pharmaceutical Preparations·BLACKSBURG, VA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Landos Biopharma, Inc. — SlamSEC

Revenue

$18.0M

FY 2022

Adj. EBITDA

-$40.0M

-222.1% margin

FY 2023

Net Income

-$39.3M

-218.2% margin

FY 2023

EPS (Diluted)

-$9.76

FY 2023

Stock Price

—

52W Range

—

P/E Ratio

—

Market Cap

—

Cash

$36.6M

FY 2023

Total Debt

—

Net Cash

$36.6M

FY 2022

Enterprise Value

—

Debt / EBITDA

0.9x

FY 2022

EV / EBITDA

—

Employees

—

Landos is a commune in the Haute-Loire department in south-central France.